Clinical Trials
6 trialsNCT06948955 2026-05-28
Expanded Access to Bezuclastinib to be Coadministered With Sunitinib for Patients With Gastrointestinal Stromal Tumors
Cogent Biosciences, Inc.
Available
NCT04714086 2024-10-24
Expanded Access Program for Avapritinib
Blueprint Medicines Corporation
No longer available
NCT04148092 2020-05-29
Expanded Access Program of Ripretinib (DCC-2618) for the Treatment of Patients With Advanced GIST
Deciphera Pharmaceuticals, LLC
Approved for marketing
NCT01689376 2016-08-16
Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy (Managed Access Program)
Bayer
No longer available
NCT01613053 2015-04-24
MACS2226
Novartis
No longer available
NCT01646593 2014-12-15
Regorafenib in Subjects With Gastrointestinal Stromal Tumors (GIST) Who Have Progressed After Standard Therapy
Bayer
No longer available